실험실 자동화 시장 예측 - 구성요소, 자동화 유형, 워크플로우 단계, 용도, 최종사용자 및 지역별 분석(-2034년)

According to Stratistics MRC, the Global Lab Automation Market is accounted for $7.5 billion in 2026 and is expected to reach $13.7 billion by 2034 growing at a CAGR of 7.8% during the forecast period. Lab automation refers to the use of technology to automate manual processes in laboratory settings, including sample handling, analysis, and data management. These systems encompass robotic workstations, automated liquid handlers, and integrated software platforms that streamline workflows across clinical diagnostics, pharmaceutical research, and biotechnology applications. The adoption of lab automation is transforming scientific workflows by increasing throughput, reducing human error, and enabling reproducibility. As laboratories face mounting pressure to process growing sample volumes with limited skilled personnel, automated solutions are becoming essential infrastructure for modern research and diagnostic facilities worldwide.

Market Dynamics:

Driver:

Increasing demand for high-throughput screening in drug discovery

Pharmaceutical and biotechnology companies are rapidly adopting lab automation to accelerate the drug development pipeline and reduce time-to-market for new therapies. High-throughput screening requires processing thousands of samples daily, a task impossible to achieve manually with acceptable accuracy and consistency. Automated systems enable researchers to test vast compound libraries against biological targets, quickly identifying promising drug candidates while eliminating repetitive strain injuries associated with manual pipetting. The rising prevalence of chronic diseases and the corresponding need for novel therapeutics further intensify this demand, making lab automation a critical competitive advantage for research organizations seeking to shorten development cycles and reduce costly delays in bringing life-saving medications to patients.

Restraint:

High initial capital investment and integration complexity

Significant upfront costs for automated systems continue to challenge widespread adoption, particularly among smaller laboratories and academic research institutions. A fully integrated automated laboratory requires substantial expenditure on robotic platforms, specialized equipment, software licenses, and infrastructure modifications. Beyond hardware costs, organizations face considerable expenses related to system integration, workflow redesign, and staff training. The complexity of connecting disparate instruments from different manufacturers into a seamless automated workflow often demands specialized technical expertise that may not be available internally. These financial and technical barriers create a tiered market where only well-funded facilities can fully benefit from comprehensive automation solutions.

Opportunity:

Artificial intelligence integration for intelligent automation

Advanced AI algorithms are revolutionizing lab automation by enabling systems that learn from experimental data and optimize protocols autonomously. Machine learning models can predict optimal assay conditions, identify anomalous results in real-time, and suggest follow-up experiments without human intervention. This intelligent automation extends beyond simple task execution to experimental design and decision-making, dramatically accelerating the pace of discovery. Laboratories implementing AI-driven automation report significant reductions in method development time and improved experimental outcomes. As AI tools become more accessible and user-friendly, even smaller laboratories can leverage these capabilities, democratizing access to sophisticated automation previously reserved for well-funded industrial research facilities.

Threat:

Workforce displacement concerns and skill gaps

Widespread automation adoption is creating tensions between operational efficiency and employment security among laboratory personnel. Technicians and scientists fear that automation will replace routine jobs, leading to resistance that can slow implementation timelines and undermine return on investment. Simultaneously, a significant skills gap exists as experienced laboratory staff lack training in robotics, software integration, and data analytics. Organizations must invest heavily in retraining programs while managing morale concerns during transitions. The perception of automation as a job threat rather than a productivity tool can create cultural barriers that are as challenging to overcome as technical hurdles, potentially limiting adoption rates in traditionally conservative laboratory environments.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated lab automation adoption as diagnostic laboratories faced unprecedented testing volumes requiring rapid turnaround times. Automated sample processing systems became essential infrastructure for meeting global testing demands, with many facilities implementing automation for the first time in response to crisis conditions. The pandemic also highlighted vulnerabilities in manual laboratory workflows, prompting permanent operational changes across clinical and research settings. Supply chain disruptions for manual consumables further incentivized automated solutions that use reagents more efficiently. The urgent need for vaccine development demonstrated automation's value in accelerating clinical trials, establishing lasting recognition of automated laboratories as critical public health infrastructure.

The Total Laboratory Automation segment is expected to be the largest during the forecast period

The Total Laboratory Automation segment is expected to account for the largest market share during the forecast period, representing fully integrated systems that automate workflows from sample entry through result reporting without manual intervention. These comprehensive solutions connect pre-analytical, analytical, and post-analytical stages through conveyor systems, robotic arms, and centralized software control, maximizing throughput and minimizing hands-on time. Large clinical diagnostic laboratories and high-volume pharmaceutical research facilities prefer total automation for its ability to process thousands of samples daily with consistent quality. The growing trend toward laboratory consolidation and centralized testing facilities further drives demand for complete automation solutions that deliver maximum operational efficiency and fastest return on investment.

The Pre-Analytical Automation segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Pre-Analytical Automation segment is predicted to witness the highest growth rate, driven by recognition that sample preparation remains the most labor-intensive and error-prone phase of laboratory workflows. Automated systems for specimen sorting, centrifugation, decapping, aliquot preparation, and sample tracking address critical bottlenecks occurring before analysis begins. Errors in this stage cannot be corrected later, making automation investments particularly valuable for quality improvement. Growing sample volumes across clinical diagnostics and biobanking applications create urgent need for efficient pre-analytical solutions. Technological advances have made these systems more compact and affordable, enabling adoption beyond large central laboratories to smaller hospital and research facilities seeking workflow improvements.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by substantial healthcare spending, leading pharmaceutical research activity, and early adoption of advanced laboratory technologies. The region hosts numerous major automation manufacturers and a dense concentration of high-volume clinical reference laboratories requiring efficient sample processing solutions. Strong research funding from government agencies like the National Institutes of Health supports continuous technology innovation. Favorable reimbursement policies for diagnostic testing and the presence of skilled technical personnel further enable automation deployment. The ongoing trend toward laboratory consolidation and centralized testing facilities across the United States and Canada ensures North America maintains its market leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by expanding healthcare infrastructure, rising pharmaceutical research investment, and growing demand for diagnostic testing across large populations. Countries including China, India, Japan, and South Korea are rapidly modernizing laboratory networks as part of broader healthcare system improvements. The region's contract research organizations are gaining global prominence, requiring competitive automation capabilities to win international business. Government initiatives supporting biotechnology development and laboratory quality standards accelerate adoption. As labor costs rise in major Asian economies and sample volumes continue increasing, the economic case for laboratory automation becomes increasingly compelling, positioning Asia Pacific as the fastest-growing regional market.

Key players in the market

Some of the key players in Lab Automation Market include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., Hamilton Company, Eppendorf SE, Qiagen N.V., Beckman Coulter Inc., Roche Diagnostics International Ltd., Siemens Healthineers AG, Hudson Robotics Inc., Aurora Biomed Inc. and Becton Dickinson and Company.

Key Developments:

In March 2026, Hamilton announced a partnership with Takara Bio USA to automate NGS library preparation, following a similar co-marketing agreement with Aplex Bio for hyperplex PCR assay kits to enhance molecular diagnostic throughput.

In February 2026, At SLAS2026, Agilent debuted new AI-driven lab optimization tools integrated into its CrossLab Connect platform, utilizing Sigsense technology to provide real-time asset analytics and predictive alerts to reduce instrument downtime.

In January 2026, BD released BD Research Cloud 7.0, featuring the BD Horizon Panel Maker, an AI-powered tool that automates the design of complex flow cytometry panels, reducing the risk of unusable data in immunology and cancer research.

Components Covered:

• Equipment
• Software & Informatics
• Services

Automation Types Covered:

• Total Laboratory Automation
• Modular Automation
• Task-Targeted Automation

Workflow Stages Covered:

• Pre-Analytical Automation
• Analytical Automation
• Post-Analytical Automation

Applications Covered:

• Drug Discovery & Development
• Clinical Diagnostics
• Genomics & Proteomics
• Microbiology
• Biobanking
• High-Throughput Screening
• Other Applications

End Users Covered:

• Pharmaceutical & Biotechnology Companies
• Clinical & Diagnostic Laboratories
• Academic & Research Institutes
• Contract Research Organizations
• Hospitals

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Lab Automation Market, By Component

• 5.1 Equipment
  • 5.1.1 Automated Workstations
  • 5.1.2 Liquid Handling Systems
  • 5.1.3 Robotic Systems
  • 5.1.4 Microplate Readers
  • 5.1.5 Storage & Retrieval Systems
  • 5.1.6 Sample Preparation Systems
  • 5.1.7 Other Equipment
• 5.2 Software & Informatics
  • 5.2.1 Laboratory Information Management Systems (LIMS)
  • 5.2.2 Electronic Lab Notebooks (ELN)
  • 5.2.3 Scientific Data Management Systems (SDMS)
  • 5.2.4 Workflow Automation Software
• 5.3 Services
  • 5.3.1 Installation & Integration
  • 5.3.2 Maintenance & Support
  • 5.3.3 Consulting Services

6 Global Lab Automation Market, By Automation Type

• 6.1 Total Laboratory Automation
• 6.2 Modular Automation
• 6.3 Task-Targeted Automation

7 Global Lab Automation Market, By Workflow Stage

• 7.1 Pre-Analytical Automation
• 7.2 Analytical Automation
• 7.3 Post-Analytical Automation

8 Global Lab Automation Market, By Application

• 8.1 Drug Discovery & Development
• 8.2 Clinical Diagnostics
• 8.3 Genomics & Proteomics
• 8.4 Microbiology
• 8.5 Biobanking
• 8.6 High-Throughput Screening
• 8.7 Other Applications

9 Global Lab Automation Market, By End User

• 9.1 Pharmaceutical & Biotechnology Companies
• 9.2 Clinical & Diagnostic Laboratories
• 9.3 Academic & Research Institutes
• 9.4 Contract Research Organizations
• 9.5 Hospitals

10 Global Lab Automation Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Thermo Fisher Scientific Inc.
• 13.2 Danaher Corporation
• 13.3 Agilent Technologies Inc.
• 13.4 PerkinElmer Inc.
• 13.5 Bio-Rad Laboratories Inc.
• 13.6 Tecan Group Ltd.
• 13.7 Hamilton Company
• 13.8 Eppendorf SE
• 13.9 Qiagen N.V.
• 13.10 Beckman Coulter Inc.
• 13.11 Roche Diagnostics International Ltd.
• 13.12 Siemens Healthineers AG
• 13.13 Hudson Robotics Inc.
• 13.14 Aurora Biomed Inc.
• 13.15 Becton Dickinson and Company